Table 1.
Study participants’ characteristics
| Parameter | Healthy volunteers(n = 12) | CAD patients(n = 23) | P value |
|---|---|---|---|
| Demographics | |||
| Age (years) | 28.67 ± 4.89 | 61.37 ± 10.93 | < 0.001 |
| Male gender | 6 (50%) | 21 (91%) | < 0.001 |
| BSA (m2) | 1.84 ± 0.22 | 1.99 ± 0.15 | < 0.001 |
| BMI (k/m2) | 22.17 ± 2.45 | 26.84 ± 2.12 | < 0.001 |
| CAD | 0 (0%) | 23 (100%) | < 0.001 |
| Volumetric and functional parameters | |||
| LVEDV (ml) | 162.33 ± 33.06 | 159.17 ± 39.98 | 0.694 |
| LVESV (ml) | 65.42 ± 14.52 | 78.78 ± 39.69 | 0.461 |
| LVSV (ml) | 97.00 ± 18.97 | 80.48 ± 17.81 | 0.021 |
| LVEF (%) | 59.75 ± 1.36 | 52.09 ± 11.29 | 0.034 |
| LVEDM (g) | 82.00 ± 25.82 | 143.96 ± 30.61 | < 0.001 |
| GLS (%) | -19.34 ± 1.28 | −17.29 ± 3.17 | 0.034 |
| GCS (%) | −20.21 ± 1.48 | − 17.67 ± 2.63 | 0.001 |
Results are reported as mean ± standard deviation or total number (percentage). CAD coronary artery disease, BSA body surface area, BMI body mass index, LV left ventricle / ventricular; LVEDV LV end-diastolic volume, LVESV LV end-systolic volume, LVSV LV stroke volume, LVEF LV ejection fraction, LVEDM LV end-diastolic mass, GLS global longitudinal strain, GCS global circumferential strain